Menu
Home
Forums
Forums
Quick Links
Search Forums
Recent Posts
job listings
catering
whistleblower info
legal help
advertise on CP
submit press release
Menu
Log in
Sign up
Search titles only
Posted by Member:
Separate names with a comma.
Newer Than:
Search this thread only
Search this forum only
Display results as threads
More...
Useful Searches
Recent Posts
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Medical Equipment/Device Sales
>
GE Healthcare
>
another nail in the coffin
>
Reply to Thread
Name:
Verification:
Answer the above question:
(
CustomImgCaptcha
By
Surrey Forum
)
Message:
<p>[QUOTE="Anonymous, post: 3186161"]While I have no love for GE after the way they treat their employees, especially those of us who were "bought" with the business, I thought it was interesting that Business Week failed to point out that Dr. Kanal has, in the past, spoken and put on seminars for one of the GE competitors (Bracco) that was not specifically mentioned in the article.</p><p><br /></p><p>It's interesting that NSF didn't raise its head until Omniscan was on the market for more than 10 years (note: I was out of the business when NSF became an issue). Perhaps one of the related causes was promotion by GE ("No speed limit;" which encouraged reps to promote vaguely off-label high dose, high flow use, which would include MRA use); maybe there is a chemical component to it as well, but the issue has occured with all brands of MR contrast, so Omniscan use in itself is not the only factor.</p><p><br /></p><p>But I'm sure GE buried their heads in the sand and didn't take a proactive stance on it ...[/QUOTE]</p><p><br /></p>
[QUOTE="Anonymous, post: 3186161"]While I have no love for GE after the way they treat their employees, especially those of us who were "bought" with the business, I thought it was interesting that Business Week failed to point out that Dr. Kanal has, in the past, spoken and put on seminars for one of the GE competitors (Bracco) that was not specifically mentioned in the article. It's interesting that NSF didn't raise its head until Omniscan was on the market for more than 10 years (note: I was out of the business when NSF became an issue). Perhaps one of the related causes was promotion by GE ("No speed limit;" which encouraged reps to promote vaguely off-label high dose, high flow use, which would include MRA use); maybe there is a chemical component to it as well, but the issue has occured with all brands of MR contrast, so Omniscan use in itself is not the only factor. But I'm sure GE buried their heads in the sand and didn't take a proactive stance on it ...[/QUOTE]
Your name or email address:
Do you already have an account?
No, create an account now.
Yes, my password is:
Forgot your password?
Stay logged in
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Medical Equipment/Device Sales
>
GE Healthcare
>
another nail in the coffin
>
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Medical Equipment/Device Sales
>
GE Healthcare
>
another nail in the coffin
>